Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/769
Title: | Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study. |
Authors: | van Woudenbergh, Geertruida J. Kuijsten, Anneleen Drogan, Dagmar Boeing, Heiner Schulze, Matthias B. van der A, Daphne L. Bueno-de-Mesquita, H. Bas Spijkerman, Annemieke M. W. Romaguera, Dora Riboli, Elio Ardanaz, Eva Barricarte, Aurelio Amiano, Pilar Beulens, Joline W. J. Sluijs, Ivonne Dahm, Christina C Overvad, Kim Chirlaque, M-Doleres Clavel, Francoise Fagher-azzi, Guy Crowe, Francesca L. Eomois, Piia-Piret Teucher, Birgit Franks, Paul W. Halkjaer, Jytte Tjonneland, Anne Khaw, Kay T. Masala, Giovanna Mattiello, Amalia Quiros, J. Ramon Rolandsson, Olov Romieu, Isabelle Sacerdote, Carlotta Sanchez, Maria-Jose Tagliabue, Giovanna Tumino, Rosario Forouhi, Nita G. Sharp, Stephen Langenberg, Claudia Wareham, Nicholas J. |
metadata.dc.contributor.authoraffiliation: | [van Woudenbergh, GJ; Kuijsten, A] Wageningen University, Division of Human Nutrition, Wageningen, The Netherlands. [Drogan, D; Boeing, H; Schulze, MB] German Institute of Human Nutrition Potsdam- Rehbruecke, Germany. [van der A, DL; Bueno-de-Mesquita, H. B; Spijkerman, AMW] National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. [Romaguera, D; Riboli, E] Imperial College London, Department of Epidemiology & Biostatistics, School of Public Health, London, United Kingdom. [Ardanaz, E; Barricarte, A] Navarre Public Health Institute, Pamplona, Spain. [Amiano, P] Public Health Division of Gipuzkoa, San Sebastian, Spain. [Beulens, JWJ; Sluijs, I] University Medical Center, Utrecht, The Netherlands. [Dahm, CC.; Overvad, K] School of Public Health, Aarhus University, Aarhus, Denmark. [Chirlaque, MD] Murcia Regional Health Authority, Spain . [Clavel, F; Fagher-azzi, G] Institut National de la Santé et de la Recherche Médicale (INSERM) and Center for Research in Epidemiology and Population Health (CESP), France. [Crowe, FL] University of Oxford, Oxford, United Kingdom. [Eomois, P; Teucher, B] German Cancer Research Center, Heidelberg, Germany. [Franks, PW] Lund University, Malmo, Sweden. [Halkjaer, J; Tjonneland, A] Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark. [Khaw, KT] University of Cambridge, Cambridge, United Kingdom. [Masala, G] Cancer Research and Prevention Institute (ISPO), Florence, Italy. [Mattiello, A] Federico II University, Naples, Italy. [Quiros, JR] Asturias Health & Health Care Council, Oviedo, Spain. [Rolandsson, O] Department of Public Health and Clinical Medicine, Family Medicine, Umea University, Umea , Sweden. [Romieu, I] International Agency for Research of Cancer, Lyon, France. [Sacerdote, C] Center for Cancer Prevention, Torino, Italy. [Sanchez, MJ] Andalusian School of Public Health, Granada, Spain. [Tagliabue, G] Cancer Registry and Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Tumino, R] Cancer Registry and Histopathology Unit, Ragusa, Italy. [Forouhi, NG; Sharp, S; Langenberg, C;Wareham, NJ] MRC Epidemiology Unit, Cambridge, United Kingdom. |
metadata.dc.contributor.group: | InterAct Consortium |
Keywords: | Té;Adulto;Anciano;Estudios de Cohortes;Diabetes Mellitus Tipo 2;Conducta de Ingestión de Líquido;Europa;Femenino;Humanos;Masculino;Mediana Edad;Dinámicas no Lineales;Cuestionarios;Riesgo;Adulto Joven |
metadata.dc.subject.mesh: | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies Medical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus, Type 2 Medical Subject Headings::Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Drinking Behavior Medical Subject Headings::Geographicals::Geographic Locations::Europe Medical Subject Headings::Check Tags::Female Medical Subject Headings::Check Tags::Female Medical Subject Headings::Check Tags::Female Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Theoretical::Nonlinear Dynamics Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Questionnaires Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk Medical Subject Headings::Chemicals and Drugs::Complex Mixtures::Biological Agents::Plant Preparations::Tea Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Young Adult Medical Subject Headings::Named Groups::Persons::Age Groups::Adult |
Issue Date: | 30-May-2012 |
Publisher: | Public Library of Science Christian Herder, German Diabetes Center -, Leibniz Center for Diabetes Research at Heinrich Heine University Duesseldorf, Germany |
Citation: | van Woudenbergh GJ, Kuijsten A, Drogan D, van der A DL, Romaguera D, Ardanaz E, et al. Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study. PLoS ONE 2012; 7(5):e36910 |
Abstract: | BACKGROUND In previous meta-analyses, tea consumption has been associated with lower incidence of type 2 diabetes. It is unclear, however, if tea is associated inversely over the entire range of intake. Therefore, we investigated the association between tea consumption and incidence of type 2 diabetes in a European population. METHODOLOGY/PRINCIPAL FINDINGS The EPIC-InterAct case-cohort study was conducted in 26 centers in 8 European countries and consists of a total of 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,835 individuals from a total cohort of 340,234 participants with 3.99 million person-years of follow-up. Country-specific Hazard Ratios (HR) for incidence of type 2 diabetes were obtained after adjustment for lifestyle and dietary factors using a Cox regression adapted for a case-cohort design. Subsequently, country-specific HR were combined using a random effects meta-analysis. Tea consumption was studied as categorical variable (0, >0-<1, 1-<4, ≥ 4 cups/day). The dose-response of the association was further explored by restricted cubic spline regression. Country specific medians of tea consumption ranged from 0 cups/day in Spain to 4 cups/day in United Kingdom. Tea consumption was associated inversely with incidence of type 2 diabetes; the HR was 0.84 [95%CI 0.71, 1.00] when participants who drank ≥ 4 cups of tea per day were compared with non-drinkers (p(linear trend) = 0.04). Incidence of type 2 diabetes already tended to be lower with tea consumption of 1-<4 cups/day (HR = 0.93 [95%CI 0.81, 1.05]). Spline regression did not suggest a non-linear association (p(non-linearity) = 0.20). CONCLUSIONS/SIGNIFICANCE A linear inverse association was observed between tea consumption and incidence of type 2 diabetes. People who drink at least 4 cups of tea per day may have a 16% lower risk of developing type 2 diabetes than non-tea drinkers. |
Description: | Journal Article; Research Support, Non-U.S. Gov't; |
URI: | http://hdl.handle.net/10668/769 |
metadata.dc.relation.publisherversion: | http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0036910 |
metadata.dc.identifier.doi: | 10.1371/journal.pone.0036910 |
ISSN: | 1932-6203 (Online) 1932-6203 (Print) |
Appears in Collections: | 01- Artículos - EASP. Escuela Andaluza de Salud Pública |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
van Woudenbergh_Tea consumption.pdf | 330,08 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.